Erbevio3/Apc3
Payments companies reported to CMS as associated with Erbevio3/Apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbevio3/Apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbevio3/Apc3
These are the largest totals companies reported as associated with Erbevio3/Apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tyler Cobbs | Phoenix, AZ | Gastroenterology (Internal Medicine) | $167.00 |
| Eliana Shaul | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Wendy Jeshion | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Shamila Zawahir | Englewood, NJ | Pediatric Gastroenterology | $8.31 |
| Payal Makadia | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Sharon Hilton | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Inna Novak | Bronx, NY | Pediatric Gastroenterology | $8.31 |
| Tracie Wong | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Elaine Moustafellos | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
| Katherine Orellana | Hackensack, NJ | Pediatric Gastroenterology | $8.31 |
Prescribed Erbevio3/Apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.